eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss the growth of the GLP-1 market and the company’s latest funding round on ‘Morning with Maria.’
As the market for GLP-1 weight loss drugs exploded to an estimated $150 billion, NFL legend Tom Brady stepped into the arena – not to promote a magic pill, but to push the clinical wave with his “TB12” discipline.
“Making a difference in the lives of others, trying to share some of the things in my mind that I learned from an amazing mentor, understanding and trying to inspire through different people who come into my life to communicate messages that I can get, that help me live my dreams, and I want to do that for others,” said Bradorning in an exclusive interview “M Maria”.
Seven-time Super Bowl champion and eMed CEO Linda Yaccarino joined forces to announce a massive $200 million funding round, valuing the digital health company at more than $2 billion. The duo aims to revolutionize “population health” by using AI and clinical oversight to provide entrepreneurs with a sustainable way to offer GLP-1 weight loss medications like Ozempic and Mounjaro, while reducing the company’s insurance claims.
“The increase confirms the great momentum and establishes us as the definitive company for population health and helps employers change the cost of health care and change the cost curve,” said Yaccarino to Bartiromo.
TOM BRADY SAYS POST-NFL LIFE IS ABOUT ‘BUILDING TRUST’ AS HE MAKES A DEAL WITH HERTZ.
“When you have people who are overweight or obese, their health care costs are double the average non-obese employee,” he said. “So that’s an unanswered question, that finally, eMed steps in, to be able to deliver that solution to employers all over the country.”
Tom Brady at the Fanatics Flag Football Classic press conference and practice at BMO Stadium on March 20, 2026, in Los Angeles. (Getty Images)
While many Americans use GLP-1s as an easy weight loss solution, Brady sees the eMed platform as a kickstart for people who don’t have the biological benefits of a natural high-potency. He emphasized that treatment should be based on a foundation of clinical support and personal accountability.
“It’s not about a shortcut for anyone. It’s about a well-delivered program for people to start their health journey in a variety of ways,” Brady explained. “I have been lucky to be around the best professionals, the best doctors, the best trainers, the best nutritionists. And I realize how lucky I was to have that guidance.”
“I really want to break the stigma around the fact that, you know, discipline and hard work and willpower is something that … we are born with. I was born with that, and I have the ability to do that. I think there are many other people that it is something that is more of a struggle,” he added. “But we need to be able to provide support for people as well.”
Seven-time Super Bowl champion Tom Brady and Aescape CEO Eric Litman discuss the NFL star’s partnership with next-generation AI massage technology in ‘The Claman Countdown.’
Brady further details how his most valuable asset requires a level of maintenance that is only now becoming mainstream.
“I realized because I’m an athlete, my body is my asset,” the former quarterback said. “If I like to play football and I like to be on the field, then I like to do my best. I have to take care of my body, you know, in a certain way. I try a lot of muscles to repair injured tissues. I hydrate all the time.
“How can I ever stop? This is my life, I tell you, I have become obsessed with exercise. I will feel horrible and worse if I do not move all the time. I feel like I have a lot of energy … I want to stay active. I have three children. I want to go out there and play basketball and swim and hit the golf ball, and play volleyball with my daughter in the backyard,” said Brady.
GET FOX BUSINESS ON THE GO BY CLICK HERE
Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight loss pill in the US, the lawsuit against Hims & Hers and talking to the Trump administration about drug prices.
Yaccarino — a former X Corp. CEO who declined to comment on Wednesday’s social media ruling — explained that eMed’s goal is to take Brady’s “rigor” and apply it to the American workforce and minimize chronic disease.
“Ninety percent of people stay in our program. They do two things: First, and most important, what Tom was referring to, they get healthier,” he said. “And when you get people in that program, when you deliver those health outcomes, that’s the secret sauce for entrepreneurs, for CEOs, CFOs — who you have on your show all the time — because they’re getting a return on their investment.”
Read more from FOX BUSINESS
#Tom #Brady #opens #health #GLP1 #surge #Water #movement #discipline